| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
T Cells Are Not Essential to the Pathogenesis of Arthritis or Colitis in HLA-B27 Transgenic Rats1
Harold C. Simmons Arthritis Research Center and Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390
The class I MHC allele HLA-B27 is highly associated with the human
spondyloarthropathies, but the basis for this association remains
poorly understood. Transgenic rats with high expression of HLA-B27
develop a multisystem inflammatory disease that includes arthritis and
colitis. To investigate whether CD8
T cells are needed in this
disease, we depleted these cells in B27 transgenic rats before the
onset of disease by adult thymectomy plus short-term anti-CD8
mAb treatment. This treatment induced profound, sustained depletion of
CD8 T cells, but failed to suppress either colitis or arthritis.
To address the role of CD8+- cells, we
studied four additional groups of B27 transgenic rats treated with: 1)
continuous anti-CD8 mAb, 2) continuous isotype-matched control
mAb, 3) the thymectomy/pulse anti-CD8 regimen, or 4) no
treatment. Arthritis occurred in 
40% of each group, but was most
significantly reduced in severity in the anti-CD8-treated group.
In addition to CD8 T cells, two sizeable
CD8+- non-T cell populations were also
reduced by the anti-CD8 treatment: 1) NK cells, and 2) a
CD4+CD8+CD11b/c+CD161a+CD172a+
monocyte population that became expanded in diseased B27 transgenic
rats. These data indicate that HLA-B27-retricted CD8+ T
cells are unlikely to serve as effector cells in the transgenic rat
model of HLA-B27-associated disease, in opposition to a commonly
invoked hypothesis concerning the role of B27 in the
spondyloarthropathies. The data also suggest that one or more
populations of CD8+- non-T cells may
play a role in the arthritis that occurs in these
rats.
This article has been cited by other articles:
|
|
 |
|
  K. G.-J. Ooi, G. Galatowicz, V. L. Calder, and S. L. Lightman Cytokines and Chemokines in Uveitis - Is there a Correlation with Clinical Phenotype? Clin. Med. Res., December 1, 2006; 4(4): 294 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Turner, D. P. Sowders, M. L. DeLay, R. Mohapatra, S. Bai, J. A. Smith, J. R. Brandewie, J. D. Taurog, and R. A. Colbert HLA-B27 Misfolding in Transgenic Rats Is Associated with Activation of the Unfolded Protein Response J. Immunol., August 15, 2005; 175(4): 2438 - 2448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Rihl, J Gu, D Baeten, E Marker-Hermann, J C Goodall, J S H Gaston, J G Kuipers, H Zeidler, and D T Y Yu Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor {alpha} and interferon {gamma} Ann Rheum Dis, December 1, 2004; 63(12): 1673 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kollnberger, L. A. Bird, M. Roddis, C. Hacquard-Bouder, H. Kubagawa, H. C. Bodmer, M. Breban, A. J. McMichael, and P. Bowness HLA-B27 Heavy Chain Homodimers Are Expressed in HLA-B27 Transgenic Rodent Models of Spondyloarthritis and Are Ligands for Paired Ig-Like Receptors J. Immunol., August 1, 2004; 173(3): 1699 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Tran, N. Satumtira, M. L. Dorris, E. May, A. Wang, E. Furuta, and J. D. Taurog HLA-B27 in Transgenic Rats Forms Disulfide-Linked Heavy Chain Oligomers and Multimers That Bind to the Chaperone BiP J. Immunol., April 15, 2004; 172(8): 5110 - 5119. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
